IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

Pharmaceutical Medicine
Shubham Atal, Zeenat Fatima

Abstract

At present, there are no proven agents for treatment of coronavirus disease (COVID-19). The available evidence has not allowed guidelines to clearly recommend any drugs outside the context of clinical trials. The novel coronavirus SARS-CoV-2 that causes COVID-19 invokes a hyperinflammatory state driven by multiple cells and mediators like interleukin (IL)-1, IL-6, IL-12, and IL-18, tumor necrosis factor alpha (TNFα), etc. Considering the proven role of cytokine dysregulation in causing this hyperinflammation in the lungs with IL-6 being a key driver, particularly in seriously ill COVID-19 patients, it is crucial to further explore selective cytokine blockade with drugs like the IL-6 inhibitors tocilizumab, sarilumab, and siltuximab. These targeted monoclonal antibodies can dampen the downstream IL-6 signaling pathways, which can lead to decreased cell proliferation, differentiation, oxidative stress, exudation, and improve clinical outcomes in patients with evident features of cytokine-driven inflammation like persistent fever, dyspnea and elevated markers. Preliminary evidence has come for tocilizumab from some small studies, and interim analysis of a randomized controlled trial; the latter also being available for sarilumab. ...Continue Reading

References

Jul 8, 2005·Nature·Yumiko ImaiJosef M Penninger
Mar 15, 2006·Lancet·Jan-Inge HenterYu-Lung Lau
Apr 4, 2006·Current Opinion in Pharmacology·Keiji KubaJosef M Penninger
Sep 14, 2006·PLoS Medicine·Lauren J StockmanPaul Garner
May 2, 2008·Experimental Physiology·Yumiko ImaiJosef M Penninger
Apr 22, 2015·Nature Immunology·Christopher A Hunter, Simon A Jones
Feb 15, 2019·Frontiers in Microbiology·I-Yin ChenTakeshi Ichinohe
Feb 23, 2020·The Lancet. Respiratory Medicine·Zhe XuFu-Sheng Wang
Feb 26, 2020·International Journal of Oral Science·Hao XuQianming Chen
Mar 3, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sufang TianShu-Yuan Xiao
Mar 13, 2020·Annals of Internal Medicine·Huilan ZhangRonghui Du
Mar 21, 2020·Lancet·Puja MehtaUNKNOWN HLH Across Speciality Collaboration, UK
Mar 24, 2020·JAMA : the Journal of the American Medical Association·Graziano OnderSilvio Brusaferro
Apr 8, 2020·Journal of Medical Virology·Pan LuoJuan Li
Apr 23, 2020·The American Journal of Tropical Medicine and Hygiene·Arjen M DondorpMarcus J Schultz
May 24, 2020·The New England Journal of Medicine·John H BeigelUNKNOWN ACTT-1 Study Group Members
Jun 9, 2020·MedRxiv : the Preprint Server for Health Sciences·Joseph MagagnoliJayakrishna Ambati
Apr 14, 2020·MedRxiv : the Preprint Server for Health Sciences·W. TangQing Xie

❮ Previous
Next ❯

Citations

Sep 23, 2020·Open Biology·Antonella FaraBakri M Assas
Aug 15, 2020·Frontiers in Immunology·Abdelouaheb Benani, Sanae Ben Mkaddem
Sep 10, 2020·International Journal of Molecular Sciences·Neelu BatraAi-Ming Yu
Aug 29, 2020·European Journal of Medical Research·Regina B PodlasinAndrzej Horban
Oct 14, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Shubham AtalSadasivam Balakrishnan
Nov 19, 2020·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Zhongyi ZhaoChuanmin Tao
Feb 3, 2021·Archivum Immunologiae Et Therapiae Experimentalis·Alicja Krejner-BieniasTomasz Grzela
Nov 17, 2020·Heart Failure Reviews·Ernest A AdeghateJaipaul Singh
Dec 4, 2020·World Journal of Clinical Cases·Moises Rodriguez-GonzalezAlvaro Antonio Perez-Reviriego
Jan 16, 2021·Microorganisms·Mai M ZaferHossam M Ashour
Feb 9, 2021·3 Biotech·Hardeep Singh TuliKatrin Sak
Feb 10, 2021·Infectious Disease Reports·Andrew R McGillShyam S Mohapatra
Dec 12, 2020·Clinical & Translational Immunology·Armando CaballeroTania Crombet
Nov 13, 2020·Frontiers in Immunology·Branca PereiraArne N Akbar
Dec 29, 2020·Open Medicine·Md Jahidul HasanShihan Mahmud Redwanul Huq
Dec 31, 2020·Pathogens·Deepmala KarmakarSanghamitra Sengupta
Feb 2, 2021·Trends in Analytical Chemistry : TRAC·Sharda KotruMatiar M R Howlader
Jan 3, 2021·The International Journal of Risk & Safety in Medicine·Kavita ManchandaHarmanjit Singh
Oct 9, 2020·Stem Cell Reviews and Reports·Himanshu AgrawalPartha Roy
Mar 2, 2021·Frontiers in Cellular and Infection Microbiology·Shamila D AlipoorIan M Adcock
Mar 13, 2021·Frontiers in Pharmacology·Angela E PeterV Lakshmi Kalpana
Mar 23, 2021·Expert Review of Clinical Immunology·Michael MahlerMarvin J Fritzler
Apr 26, 2021·Pharmacology & Therapeutics·Xuhui TongDapeng Chen
May 13, 2021·ACS Biomaterials Science & Engineering·Elham BidramPooyan Makvandi
May 19, 2021·Infectious Agents and Cancer·Giuseppe PannoneLorenzo Lo Muzio
May 18, 2021·Frontiers in Pharmacology·Sha LiYibin Feng
Jun 22, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shetty Ravi DyavarDeepak B Salunke
Jun 22, 2021·Journal of Infection and Public Health·Rizaldy Taslim PinzonRanbebasa Bijak Buana
Aug 6, 2021·Journal of Anaesthesiology, Clinical Pharmacology·Shibu SasidharanGurpreet Kaur Dhillon
Aug 28, 2021·Biological Trace Element Research·Ali BahramiFatemeh Nouri
Oct 10, 2021·International Journal of Clinical Practice·Fatma Kesmez CanSelma Sezen
Jan 14, 2022·Communications Biology·Christopher J NeufeldtRalf Bartenschlager

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04310228
NCT04320615
NCT04317092
NCT04315480
NCT04322773
NCT04331808
NCT04315298
NCT04324073
NCT04329650
NCT04322188

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here